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Community-onset sepsis and its public
health burden: a systematic review
Alexander Tsertsvadze1*, Pam Royle1, Farah Seedat2, Jennifer Cooper2, Rebecca Crosby2 and Noel McCarthy1,3
Abstract
Background: Sepsis is a life-threatening condition and major contributor to public health and economic burden
in the industrialised world. The difficulties in accurate diagnosis lead to great variability in estimates of sepsis
incidence. There has been even greater uncertainty regarding the incidence of and risk factors for community-onset
sepsis (COS). We systematically reviewed the recent evidence on the incidence and risk factors of COS in high
income countries (North America, Australasia, and North/Western Europe).
Methods: Cohort and case-control studies were eligible for inclusion. Medline and Embase databases were
searched from 2002 onwards. References of relevant publications were hand-searched. Two reviewers screened
titles/abstracts and full-texts independently. One reviewer extracted data and appraised studies which were
cross-checked by independent reviewers. Disagreements were resolved via consensus. Odds ratios (ORs) and 95
percent confidence intervals (95 % CIs) were ascertained by type of sepsis (non-severe, severe, and septic shock).
Results: Ten cohort and 4 case-control studies were included. There was a wide variation in the incidence (# cases
per 100,000 per year) of non-severe sepsis (range: 64–514), severe sepsis (range: 40–455), and septic shock (range:
9–31). Heterogeneity precluded statistical pooling. Two cohort and 4 case-control studies reported risk factors for
sepsis. In one case-control and one cohort study, older age and diabetes were associated with increased risk of
sepsis. The same case-control study showed an excess risk for sepsis in participants with clinical conditions
(e.g., immunosuppression, lung disease, and peripheral artery disease). In one cohort study, higher risk of sepsis
was associated with being a nursing home resident (OR = 2.60, 95 % CI: 1.20, 5.60) and in the other cohort study with
being physically inactive (OR = 1.33, 95 % CI: 1.13, 1.56) and smoking tobacco (OR = 1.85, 95 % CI: 1.54, 2.22). The
evidence on sex, ethnicity, statin use, and body mass index as risk factors was inconclusive.
Conclusions: The lack of a valid standard approach for defining sepsis makes it difficult to determine the true
incidence of COS. Differences in case ascertainment contribute to the variation in incidence of COS. The evidence on
COS is limited in terms of the number and quality of studies. This review highlights the urgent need for an accurate
and standard method for identifying sepsis. Future studies need to improve the methodological shortcomings of
previous research in terms of case definition, identification, and surveillance practice.
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Background
Health and economic burden
Sepsis is a complex life-threatening condition characterised
by the host’s systemic inflammatory immune response to
infection, which may lead to organ damage, organ failure,
septic shock, and death [1]. Sepsis with its associated com-
plications remains a major public health and economic bur-
den in the industrialised world [2]. Outcomes of sepsis may
have serious short- or long-term consequences such as am-
putation, damage to organs, or cognitive dysfunction. In
the US, treatment of a patient with sepsis may cost up to
$50,000, translating to an annual nationwide economic bur-
den of $17 billion [3, 4]. In European studies, the treatment
of severe sepsis in 2002 was estimated to cost approxi-
mately £25,000 [5]. Assuming an incidence of 100,000 new
cases per year, the UK’s National Health Service (NHS)
expenditure for treating these cases would amount to £2.5
billion annually [6].
Estimates of sepsis incidence vary, which may be due
to the lack of a uniform definition, disease heterogeneity,
and differences in data sources/case ascertainment
(e.g., clinical registries, hospital discharge databases, or
vital statistics records) [4]. Large nation-wide cohort stud-
ies conducted in five high-income countries (the UK, the
USA, Australia, France, and New Zealand) [3, 4, 7–9],
showed a wide variation in the annual incidence of severe
sepsis ranging from 51 [7] to 300 [3] cases per 100,000
population.
Furthermore, the evidence accumulated over the past
two decades has shown a gradual increase (8 %-13 % per
year) in the incidence of sepsis in high-income countries
(the UK, the USA) [4, 10–12]. This trend could be due
to the effects of aging populations (e.g., higher propor-
tions of elderly, type-II diabetes, cancer) and improve-
ments in the methods of detection [13, 14].
Definition and diagnosis
The current definition of sepsis introduced in 1991 [15]
and updated in 2001 [1] encompasses the presence of in-
fection and more than one of the Systemic Inflammatory
Response Syndrome (SIRS) criteria including: a) body
temperature [>38 °C or <36 °C], b) heart rate [>90 beats/
min], c) hyper-ventilation [respiratory rate >20 breaths/
min or PaCo2 < 32 mmHg], and d) White Blood Cell
Count [>12,000 cells/μL or < 4,000 cells/μL]. According
to this definition, sepsis with organ dysfunction and
sepsis with acute circulatory failure with arterial
hypotension have been termed as severe sepsis and sep-
tic shock, respectively [1]. The utility of joint infection
and SIRS criteria as a diagnostic tool is limited owing
to its high sensitivity and low specificity [10, 16]. Some
authors have suggested that this definition should
additionally incorporate a more specific sign of sepsis
that provides evidence of organ dysfunction [13, 14].
The variation in case definition complicates the com-
parison of findings across studies.
Community-onset sepsis
Depending on the place of acquisition, sepsis is classified
into community-onset and hospital-acquired (i.e., nosoco-
mial) infection [17]. The two contexts of sepsis acquisition
differ in the host characteristics (e.g., demographics,
risk profile, resistance patterns), pathogens, and outcomes
[18–21]. The definition of community-onset sepsis (COS)
in the literature has not been consistent [22]. One widely
used definition of COS is the presence of positive blood
culture and SIRS criteria before or within 48 hours of
hospital admission [19, 21, 23–25]. The majority of studies
have not attempted to distinguish between COS and
hospital-acquired sepsis. This is an important evidence-
based gap for planning public facing interventions.
In this systematic review, we aimed to synthesise the
recent evidence on the incidence and risk factors of COS
in the western industrialised world (North America,
Australasia, and North/Western Europe). This independent
review was undertaken to provide evidence for Public
Health England (PHE). Motivation for estimating the
overall burden and risk factors of COS was to contribute
information for community-based interventions to guide
patients and the public in health-care seeking behaviour.
Methods
This review was conducted based on the previously
published protocol [26]. The modification of quality
assessment strategy was the only deviation from the
methodology described in the protocol. This review
is reported according to the recommendations from
the Preferred Reporting Items for Systematic Review
and Meta-Analysis (PRISMA) statement. The corre-
sponding PRISMA checklist is provided as an
Additional file 1 [27].
The review focused on the evidence from countries lo-
cated in North America, Australasia, and North/Western
Europe. Given the longitudinal changes in the incidence,
modifications in the definition [10] and introduction of
ICD-9 coding of sepsis [28], we restricted our focus to
studies providing data that had been collected in 2002 or
onwards.
Study inclusion criteria
English-language full-text reports of cohort and case-
control studies reporting incidence of and/or risk factors
for COS were included.
 Study setting: population- or hospital-based studies
considering COS separately
 Population: community dwellers, hospitalised
patients (male/female) of any age (except for
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neonates) from a defined population with or without
COS at study baseline. The study used relevant
ICD-9/10 codes [3, 4] and established criteria for the
diagnosis of sepsis [1].
 Exposure/risk factor: any patient characteristic or
clinical parameter (e.g., age, sex, co-morbidity,
heart rate, body temperature) associated with a
risk of COS
 Outcome: annual incidence (per population/hospital
admission) of COS; risk factors for COS.
We excluded studies of nosocomial sepsis and those
unable to differentiate COS; intervention and prognos-
tic studies; studies reporting only single-site infection
or single infecting species; and studies limited to spe-
cific subgroups (e.g., neonates) or clinical conditions
(e.g., cancer, coronary heart disease).
Search strategy
We searched Medline and Embase from 01 January,
2002 to May 8, 2015, using a combination of subject
headings and keywords for sepsis and related terms
combined with terms for epidemiology and community
based settings.
We searched for unpublished literature through the
following sources: a) hand search of reference lists, b)
relevant websites of organizations dealing with sepsis
(International Sepsis Forum, Sepsis Trust UK, Sepsis
Alliance, Centre for Disease Control, World Sepsis Day),
c) contacting experts in the field, d) theses database
(index to theses), and e) Google Scholar (government or
other reports). We did not search abstracts from confer-
ence proceedings, since they do not have full texts and
therefore do not provide sufficient information to verify
a) how sepsis was diagnosed, b) whether study popula-
tion had COS or other sepsis, and c) details on incidence
and risk factors. The Medline and Embase search strat-
egies are provided in Additional file 2.
Study selection
All bibliographic records identified were compiled and
de-duplicated in an endnote database. Two independent
reviewers (AT and FS) using a pre-defined piloted form
screened all titles/abstracts and later full text reports of
potentially eligible records. Disagreements at both levels
were resolved via consensus.
Data extraction
One reviewer (AT) used a pre-piloted sheet and extracted
relevant information before it was checked by two inde-
pendent reviewers (JC and RC). Disagreements between
the reviewers were resolved via consensus. The extracted
data included information on study (e.g., author name, year
of publication, country of conduct, design, study setting,
sample size), risk factors (e.g., socio-demographic charac-
teristics, co-morbidities, clinical symptom or parameter),
and outcomes (e.g., definition of sepsis, type of pathogen,
incidence). Missing statistical parameters of importance
were calculated, if data permitted. The data extraction
sheet is provided in Additional file 3.
Quality assessment
Methodological quality of studies was appraised by one
reviewer (AT) and checked independently by another re-
viewer (JC). The assessments were done using two
checklists by the Scottish Intercollegiate Guidelines Net-
work (SIGN) for cohort [29] and case-control studies
[30]. We selected these tools based on the guidance for
evidence-based decision making in infectious diseases
epidemiology, prevention, and control proposed by
Harder and colleagues [31].
Both checklists address five sources of bias: study re-
search question, participant selection, information bias,
confounding, statistical analysis, and an overall assess-
ment of the study (i.e., summary judgement on internal
and external validity). The overall quality ratings (high,
acceptable, or low) were based on the extent to which
the pre-selected important domains of bias were affected
in cohort (Selection of subjects: items 4–5; Assessment:
items 7, 10–11; Confounding: item 13) and case-control
studies (Selection of subjects: items 3–4, 6–7; Assess-
ment: item 9; Confounding: item 10). The checklists and
assessments are provided in Additional file 4.
Data analysis and synthesis
The evidence was synthesized and organised in summary
tables and text. The incidence and risk factor data were
stratified by study design and sepsis severity: non-severe,
severe, and septic shock. The overall sepsis incidence
was expressed as the annual number of new cases per
population, cumulative incidence proportion (CIP; in %)
or incidence density rate (IDR). The association between
risk factors and sepsis was expressed with odds ratios
(ORs) and hazard rate ratios (HRRs) with 95 percent
confidence intervals (95 % CIs).
Meta-analysis could not be performed due to extensive
heterogeneity across study population characteristics, ex-
posure definitions, and the outcome measurement meth-
odology. The scarcity of evidence did not permit to
determine the effects of publication bias and the con-
duct of sub-group analysis by age, sex, study setting, and
place of acquisition (community-acquired vs. healthcare-
associated community onset).
Results
Literature search and included studies
All the searches (electronic databases, hand search,
contacting authors, and auto alerts) identified 6,351
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bibliographic records. No additional records were found
through the websites of sepsis organizations, theses data-
base, and Google Scholar.
After duplicates were removed, a total of 4,305 titles/
abstracts were screened, of which 275 passed to full text
screening level. Of the 275 full text reports examined,
only 22 met the inclusion criteria (representing 14 stud-
ies) [11, 32–52]. The study selection process and reasons
for exclusion at the full-text screening level are pre-
sented in Fig. 1 (the PRISMA Flow Diagram) [27].
Fig. 1 PRISMA Flow Diagram
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Of the 14 included studies, 10 were cohort studies
[11, 32–38, 40–42, 46–52] and 4 case-control studies
[39, 43–45].
One cohort study, which was supported by 9 publica-
tions [32–38, 40, 41], used the data from the Reasons for
Geographic And Racial Differences in Stroke
(REGARDS) study database [53]. In this review, this co-
hort study is referred as the REGARDS-sepsis cohort
study and as a whole it is referenced as Wang et al. 2012
[36]. Two case-control studies by Wang et al. [39] and
Henriksen et al. [43] were based on the data from the
REGARDS-sepsis study [36] and the cohort study by
Henriksen et al. [42], respectively. Although based on
the same cohort data, these two case-control studies
have been treated as distinct entities from their cohort
study counterparts in the data synthesis because of the
different design and outcomes reported (i.e., no overlap
or double-counting of studies per outcome). The Wang
et al. case-control study [39] is referred to as the
REGARDS-sepsis case-control study.
Study and population characteristics
Study population characteristics for the included studies
are provided in Table 1 (cohort studies) and Table 2
(case-control studies).
Cohort studies
Of the 10 cohort studies, 4 were of prospective [36, 42,
46, 49] and 6 were of retrospective design [11, 47, 48,
50–52].
In most studies, the settings were emergency depart-
ments, intensive care units, high dependence units, and
hospital wards. The geographic scope of catchment area
varied from nationwide [11, 36, 47, 48, 50, 52] to regional
[51] or municipal [42, 46, 49]. The length of follow-up
ranged from 4 months [46] to 10 years [36, 51].
Studies enrolled cohorts of patients hospitalised,
admitted, or visiting ED/ICU for different reasons
(e.g., medical, surgery, trauma, or infection) [11, 42,
46–50, 52]. The REGARDS-sepsis cohort study was
the only study with a well-defined study-base sample
which consisted of community-dwelling people who
were sepsis-free at the study baseline [36]. The
population in the REGARDS-sepsis cohort study in-
cluded those aged 45 years or older [36].
The majority of studies used the standard consensus-
based criteria for non-severe and severe sepsis as out-
lined by Levy et al. [1]. Only 5 studies reported defini-
tions of COS explicitly (i.e., sepsis manifested within the
first 24–48 hours of admission) [11, 36, 42, 49, 50].
Data sources utilised were administrative databases
ranging from clinical records [11, 36, 42, 46, 49, 52] to
hospital discharge records [47, 48, 50]. One study used
an emergency medical services encounters database
linked with hospital discharge records [51].
Case-control studies
This review included 4 case-control studies [39, 43–45].
The REGARDS-sepsis case-control study [39], analysed
only a subset of 162 case-control matched pairs sampled
from the REGARDS-sepsis cohort study. In contrast,
Henriksen et al. [43], analysed all sepsis cases (n = 1,713)
and controls (n = 227,054; residents not hospitalised up
to 7 days before the index date) from the cohort study
base [42]. The study by Jovanovich et al. [44] investi-
gated 211 matched case-control pairs admitted to ter-
tiary care centres, small clinics, and hospitals. Legras
and colleagues [45], analysed 211 matched case-control
(mild bacterial infection) pairs admitted to intensive care
units or hospital wards. The sepsis definitions used were
based on the standard criteria [1] and ICD-9 codes
(995.91, 995.92).
Quality of included studies
Methodological quality assessments are presented in
Additional file 4 (Table S1: cohort studies and Table S2:
case-control studies).
Cohort studies
Of the 10 cohort studies, only 4 were rated as of accept-
able quality [11, 36, 42, 46]. The 6 remaining studies
were judged to be of low quality [47–52]. Poor reporting
(item response: can’t say) for the absence of outcome at
baseline (item 4) and the validity of methods for the out-
come assessment (item 11) were main contributory fac-
tors for the cohort studies judged to be of low quality.
Also, it was not clear how comparable the exposure
groups in these studies were. Three cohort studies with
acceptable quality were of prospective design and de-
scribed explicitly defined populations free of sepsis at
baseline (i.e., denominators) [36, 42, 46].
Case-control studies
All 4 case-control studies were of low quality [39, 43–45].
Specifically, the controls in three studies were cases
hospitalised for serious infection (item 7) [39], mild
bacterial infection [45], or non-specified medical con-
dition [44]. Only one study utilised true non-cases as
controls [43]. It was not clear if the same exclusion
criteria was applied to both cases and controls for
two studies [43, 44] and how valid the exposure
measurement was in two studies [43, 45].
Review outcomes
Incidence of COS
Data on the incidence of COS is provided in Table 3.
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Table 1 Study and population characteristics: cohort studies
Study ID year
[country]
Study
characteristics
Population characteristics Case identification and data source Exposure and follow-up
Esteban 2007
[46] Spain
Design:
prospective
Case definition and criteria used:
ACCP/SCCM definitions μ
Case report forms Exposure: Not defined
Study setting:
ICU, hospital ward
Criteria for COS: 83% sepsis patients
had a community-acquired infection
(no other details given)
FU: March 1, 2003 to June
30, 2003
Geographic
scope: city/
municipal
Inclusion criteria: Consecutively
admitted patients (age≥18 years)
FU duration: 4 months
Recruitment
years: March 1,
2003 to June 30,
2003
Description (n sample size): 15,852
(includes n=702 non-severe sepsis
cases)
Ginde 2013
[47] The USA
Design:
retrospective
Case definition and criteria used:
Severe sepsis as concurrent bacterial or
fungal infection plus acute organ
dysfunction using ICD-9-CM codes
(995.92) for infection and acute organ
dysfunction
Annual survey of ED visits conducted
by the National Centre for Health
Statistics (associated with U.S. non-
institutional, general and short stay
hospitals)
Exposure: Age, nursing
home residence
Study setting:
nursing residence,
community-living,
ED
FU: 2005 to 2009
Criteria for COS: patients admitted to
ED for severe sepsis
FU duration: 5 years
Geographic
scope:
Nationwide
Inclusion criteria: adults (≥18 years)
who visited ED (with or without
infection other than sepsis)
Recruitment
years: 2005–2009
Description (n sample size): a
nationally representative survey of all
ED visits of adults (age ≥ 18 years) in
2005–2009 (n=87,500,000)
Harrison 2006
[11] The UK
Design:
retrospective
Case definition and criteria used:
severe sepsis - infection plus ≥3 SIRS
criteria and ≥1 organ dysfunction
during the 24-hour period
The Case Mix Programme Database
containing data on demographics,
case mix, outcome and activity for
admissions. Patient data were
abstracted by trained data collectors
according to precise rules and
definitions
Exposure: not defined
Study setting:
ICU and
combined ICU/
HDU
FU: December 2001 to
January 2005
Criteria for COS: as having severe
sepsis during the first 24 hours
following admission to the critical care
unitGeographic
scope:
Nationwide
(England, Wales,
and Northern
Ireland)
FU duration: 2 years (2002-
2004)
Inclusion criteria: adults (≥16 years)
presenting with severe sepsis within 24
hours of admission to critical care
Description (n sample size):
n=59,388 (2002), n=59,527 (2003),
n=24,905 (2004)
Recruitment
years: December
1995 to January
2005
Henriksen
2015a [42]
Denmark
Design:
Prospective
Case definition and criteria used:
the ACCP/SCCM criteriaμ
The hospitals’ patient administrative
database and electronic patient
records which were manually
reviewed.
Exposure: age, sex
Study setting:
medical ED, ICU,
community-based
Criteria for COS: Patient had an
infection at arrival or developed an
infection during the first 48 hours after
admission.
FU: September 1, 2010 to
August 31, 2011
FU duration: 12 months
Geographic
scope: city/
municipal
Inclusion criteria: adults (≥15 years)
admitted to the medical ED or directly
to the medical ICU
Description (n sample size): A
population-based survey of all adult
Recruitment
years: September
1, 2010, to August
31, 2011
patients admitted to the medical ED at
Odense University Hospital, Denmark
(n=235,598); n=8,358 hospitalisations
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Table 1 Study and population characteristics: cohort studies (Continued)
Husak 2010
[48] Canada
Design:
retrospective
Case definition and criteria used:
Severe sepsis (including septic shock) -
sepsis complicated by organ
dysfunction in at least one of the six
organ systems and the ICD codes
Hospital discharge abstract database Exposure: Not defined
Study setting:
hospital ward, ED,
ICU
FU: April 1, 2004 to March
31, 2009
Geographic
scope:
Nationwide
Criteria for COS: the majority (79%) of
patients with sepsis were admitted via
the EDs, while 12.4% were admitted
directly through hospitals
FU duration: 5 years
Recruitment
years: April 1,
2004 to March 31,
2009
Inclusion criteria: NR
Description (n sample size): sepsis
cases n=26,803 (2004-2005), n=30,587
(2008-2009), n for non-cases (all non-
sepsis hospitalizations): NR
Nygard 2014
[49] Norway
Design:
prospective
Case definition and criteria used:
ACCP/SCCMμ and SCCM/ESICM/ACCP/
ATS/SIS
Clinical data were registered
prospectively until hospital discharge
or in-hospital death using predefined
case report forms. Information was
collected from medical records, patient
charts, and the intensive care
electronic monitoring system
Exposure: not defined
Study setting:
ED, ICU, HDU, and
combined ICU/
HDU
FU: January 2008 to
December 2008Criteria for COS: if they developed
severe sepsis within 24 hours of
admission to the primary institution FU duration: 12 months
Geographic
scope: city/
municipal
Inclusion criteria: patients > 15 years
of age hospitalized due to COS,
including patients transferred from
affiliated hospitals, if they developed
severe sepsis within 24 hours of
admission to the primary institution
Recruitment
years: January
2008 - December
2008 Description (n sample size): total N
hospitalisations (NR); n=220 severe
sepsis cases; non-cases (n): 350,000
population
Page 2015 [50]
The USA
Design:
retrospective
Case definition and criteria used:
severe sepsis was defined using the
methodology of Angus et al.
identifying hospitalizations with the
presence of ICD-9 discharge diagnoses
for both a serious infection and organ
dysfunction
Hospital discharge data from the UHC
representing 300 academic and
community hospitals across 42 states.
Using medical record review, coders
assigned discharge diagnoses for each
hospitalization
Exposure: not defined
Study setting: NR FU: January 1, 2012 to
December 31, 2012
Geographic
scope:
Nationwide
FU duration: 12 months
Recruitment
years: January to
December 2012
Criteria for COS: Hospitalizations with
an infection present at admission were
subdivided into healthcare-associated
(admitted from nursing facility,
receiving home healthcare, or were on
haemodialysis prior to admission),
community acquired (from the
community). Those discharged without
infections at admission were
categorized as hospital-acquired
Inclusion criteria: all hospital
discharges from January 1, 2012 to
December 31, 2012
Description (n sample size):
n=3,355,753 hospitalisations; non-cases
n (population)=NR
Wang 2012 [36]
REGARDS-
sepsis cohort
study The USA
Design:
prospective
Case definition and criteria used: An
infection plus ≥ 2 SIRS criteriaμ
Structured interviews, in-home visits,
lab results, monitoring every 6 months,
medical and hospital admission
records (clinical and lab data)
Exposure: anthropometric,
socio-demographic, dietary,
and life-style factors, chronic
conditions, and statin use
Study setting:
Community-based,
hospital ward, ED
Criteria for COS: cohort of
community-dwelling individuals. The
study focused on individuals
presenting to the hospital or ED with
community-acquired sepsis
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All sepsis The incidence of all sepsis (per population)
was reported in two studies [42, 48]. The study by Henrik-
sen et al. observed 727 sepsis cases (non-severe, severe,
and septic shock; 95 % CI: 693, 762) per 100,000 popula-
tion per year [42]. The incidence of all sepsis (non-severe
and severe) in the study by Husak et al. was estimated to
be 103 cases (95 % CI was not reported and could not be
calculated) per 100,000 population per year [48].
Non-severe sepsis The incidence of non-severe sepsis
(per population) reported in 4 studies [36, 42, 46, 48]
ranged from 64 (95 % CI not available) [48] to 514 (95 %
CI: 489, 539) [36] cases per 100,000 population per year.
Of these, two studies by Esteban et al. [46] and Henrik-
sen et al. [42] reported the incidence of 367 (95 % CI:
352, 384) and 264 (95 % CI: 243, 285) cases, respectively
per 100,000 population per year.
Severe sepsis The incidence of severe sepsis (per popu-
lation) was estimated and provided in 5 studies [11, 42,
46, 48, 49].
The reported estimates across 4 studies [11, 46, 48, 49]
ranged from 40 (95 % CI not available) [48] to 104 (95 %
CI: 96, 113) [46] cases per 100,000 population per year.
The cohort study by Henriksen et al. reported an inci-
dence of 455 (95 % CI: 428, 482) cases of severe sepsis
per 100,000 population per year [42].
Six studies also reported the incidence of severe sepsis
(per hospitalisation or ED visit) which ranged from 0.22 %
(95 % CI not available) [49] to 8.12 % (95 % CI: 8.10, 8.15)
[50] per hospitalisation/ED visit per year. The incidence of
Table 1 Study and population characteristics: cohort studies (Continued)
Geographic
scope:
Nationwide
Inclusion criteria: NR
Description (n sample size):
Community-dwelling ≥45 years old
individuals in the US (n=30,239)
FU: 5 February, 2003 to 31
December, 2012
Recruitment
years: 2003-2007 FU duration: ≥ 7 years
Seymour 2012
[51] The USA
Design:
retrospective
Case definition and criteria used:
Hospitalization with severe sepsis using
the ICD-9-CM (995.92 and 785.52).
Criteria for COS: pre-hospital severe
sepsis
EMS reports computerized database
including dispatch, demographic,
clinical, and transport data for each
incident. EMS data were linked to
hospital discharge records
Exposure: not defined
Study setting:
pre-hospital EMS
FU: 2000 to 2009
FU duration: 10 years
Geographic
scope: regional
(King County in
Washington State)
Inclusion criteria: all adult EMS
encounters involving non-trauma,
non–cardiac arrest patients transported
from a scene to a receiving hospital by
ground ambulance
Recruitment
years: 2000-2009
Description (n sample size): all 2000-
2009 EMS encounters in the area of 1.2
million residents (n=407,176)
Wang 2007 [52]
The USA
Design:
retrospective
cohort study
Case definition and criteria used:
the criteria by ACCP/SCCMμ and
SCCM/ESICM/ACCP/ATS/SIS; ICD-9
codes 990.90 and 995.92 as sepsis and
severe sepsis, respectively
The study used the 2001–2004
NHAMCS public use data set which is
a national sample of ED and
outpatient visits at hospitals across the
US
Exposure: not defined
FU: 2001 to 2004
Study setting: ED FU duration: 4 years
Geographic
scope:
Nationwide
Criteria for COS: patients with severe
sepsis presenting to ED
Inclusion criteria: adults (≥18 years)
presenting to EDs during 2001-2004
(with or without severe sepsis)
Recruitment
years: 2001-2004
Description (n sample size):
n=113,123 ED visits (sample-based 4
years); 4-year national estimate
n=331,531,000 ED visits; annual
national estimate n=82,883,000 ED
visits
NR not reported, COS community-onset sepsis, ICU intensive care unit, HDU high dependency unit, FU follow-up, SIRS systemic inflammatory response syndrome,
REGARDS Reasons for Geographic And Racial Differences in Stroke, MI myocardial infarction, CAD coronary artery disease, DVT deep vein thrombosis, ED
emergency department, AF atrial fibrillation, BMI body mass index, WC waist circumference, PAD peripheral artery disease, TV television, NHAMCS National Hospital
Ambulatory Medical Care Survey, ICD-9 CM International Classification of Disease, Ninth Revision Clinical Modification, IQR interquartile range, ACCP/SCCM
American College of Chest Physicians/Society of Critical Care Medicine, ESICM European Society of Intensive Care Medicine, ATS American Thoracic Society, SIS
Surgical Infection Society, ICD-10-CA International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Canada, CCI Canadian
Classification of Health Interventions, EMS emergency medical services
μ International Sepsis Definitions Conference [1]
β REGARDS-sepsis cohort study publications [32–38, 40, 41]
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Table 2 Study and population characteristics: case-control studies
Study ID year
[country]
Study characteristics Population characteristics Identification and data source
Henriksen 2015b
[43] Denmark
Study setting: medical
ED, ICU, community-based
Case definition: sepsis (non-severe), severe sepsis, or
septic shock according to the ACCP/SCCM criteria.
Data electronically extracted from the
patient’s records and validated by trained
data. All admissions were manually
reviewed. Predefined risk factors retrieved
from several population-based registers
Control definition: all adults (≥15 years) with
residence in the hospital catchment-area (N = 235,598)
during the study period who had not been
hospitalized up to 7 days before the index date.
Geographic scope: city/
municipal
Recruitment years:
September 1, 2010 to
August 31, 2011
Criteria for COS: Patient had an infection at arrival
within the first 48 hours after admission
Inclusion criteria (cases): All adults (≥15 years)
admitted to the medical ICU or ED.
Inclusion criteria (controls): see controls definition
and criteria
Exclusion criteria: cases with a prior hospitalization up
to 7 days before the current admission. Patients
transferred from other hospitals, patients residing
outside the hospitals catchment-area at the time of
admission and patients who were unidentified
throughout the entire course of admission
N cases: 1,713 sepsis of any severity (n=621 non-severe
sepsis, n=1,071 severe sepsis, and n=21 septic shock)
N controls: 227,054
Jovanovich 2014
[44] The USA
Study setting: tertiary-
level care centres and
small clinics and hospitals
Case definition: adults hospitalized for sepsis or severe
sepsis; ICD-9 codes (995.91, 995.92)
Electronic health and administrative data
Control definition: randomly selected adult patients
without sepsis diagnosis admitted within the same
time period and matched 1:1 with cases by age, sex,
race, and season of 25(OH)D measurement
Geographic scope: Inter-
State (Utah and Idaho)
Criteria for COS: community-living adults
Inclusion criteria (cases): NR
Inclusion criteria (controls): NR
Recruitment years: 1
January 2008 and 31
December 2010
Exclusion criteria: NR
N cases: 211
N controls: 211
Legras 2009 [45]
France
Study setting: ICU,
hospital ward
Case definition: the ACCP/SCCM criteria was used
(severe sepsis or septic shock)
Medical histories and data on previous
prescriptions obtained from relatives and
general practitioner. NSAID use was
quantified by listing all the drugs taken
during the observation period, and
standard interviews were conducted by
physicians
Geographic scope:
regional
Control definition: Participants admitted to hospital
for mild bacterial infection (without severe sepsis or
septic shock)
Recruitment years:
February 2004 to
November 2005
Criteria for COS: Community-acquired (NR)
Inclusion criteria (cases): Participants >15 years
admitted to an ICU with community-onset severe
sepsis or septic shock
Inclusion criteria (controls): Participants admitted
to hospital for mild bacterial community-acquired
(non-sepsis) infection
Exclusion criteria: chronic kidney failure (creatinine
clearance <30 ml/min), pregnancy, nosocomial
infection, or congenital/acquired immunosuppression
(defined as the presence of metastatic neoplasia,
haemopathy, aplasia before the onset of sepsis), AIDS
(independently of CD4+ T-cell count)
and chronic administration of immunosuppressive
treatments
N cases: n=152 (n=34 sever sepsis; n=118 septic shock)
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severe sepsis reported in the study by Harrison et al. was
27.87 % (95 % CI: 27.52, 28.24) [11] per hospitalisation.
The incidence of community-acquired severe sepsis (per
hospitalisation) was higher compared to healthcare-
associated severe sepsis (5.75 % vs. 2.37 %) [50].
Septic shock The incidence estimates for septic shock
reported in two studies were 31 (95 % CI: 27, 36) [46]
and 9 (95 % CI: 6, 13) [42] per 100,000 population per
year.
Associations between various factors and the occurrence of
sepsis
Two cohort [36, 47] and 4 case-control studies [39, 43–45]
contributed relevant data. The associations between
socio-demographic factors and COS are provided in
Table 4.
Age One prospective cohort study indicated an increased
risk of non-severe sepsis with older age (≥75 years vs. 45–
54 years; OR crude =3.87, 95 % CI: 2.80, 5.35) [36]. In con-
trast, the cohort study by Ginde et al., showed no such
evidence (≥65 years vs. <65 years; OR adjusted =1.00, 95 %
CI: 0.52, 1.90) [47]. One case-control study showed older
age (≥85 years vs. 15–64 years) to be associated with an
increased risk of all sepsis (OR adjusted =6.02, 95 % CI: 5.09,
7.12), non-severe sepsis (OR adjusted =3.66, 95 % CI: 2.74,
4.88), and severe sepsis (OR adjusted =7.84, 95 % CI: 6.38,
9.63) [43].
Sex One prospective cohort (the REGARDS-sepsis)
study found a significantly increased risk of non-severe
sepsis in men compared to women (HRR crude =1.30,
95 % CI: 1.15, 1.48) [36]. In the other cohort study, the
risk of severe sepsis in men was not significantly differ-
ent from that in women (OR adjusted =1.13, 95 % CI:
0.62, 2.00) [47]. One case-control study [43] showed no
significant difference between men and women in risk
for all (OR adjusted =1.01, 95 % CI: 0.91, 1.11) or severe
sepsis (OR adjusted =1.07, 95 % CI: 0.95, 1.22).
Table 2 Study and population characteristics: case-control studies (Continued)
N controls: 152
Wang 2013c [39]
REGARDS-sepsis
case-control study
The USA
Study setting:
community-based,
hospital, ED
Case definition: laboratory confirmed infection plus ≥
2 SIRS criteria
Structured interviews, in-home visits, lab
results, monitoring every 6 months,
medical and hospital admission records
(clinical and lab data); blood samples
collected from fasting subjects at their
homesControl definition: hospitalized for a serious infection
(but did not meet sepsis criteria)
Criteria for COS: cohort of community-dwelling
individuals. Presentation to the hospital consisted of
the time of Emergency Department triage or admission
to inpatient unit (for participants admitted directly to
the hospital). To allow for acute changes in the
participant's condition during early hospitalization, we
used vital signs and laboratory test results for the initial
28 h of hospitalization. Our study focused on
individuals presenting to the hospital or ED with
community-acquired sepsis. We did not include
“hospital-acquired” sepsis developing at later points of
hospitalization
Geographic scope:
Nationwide
Recruitment years:
January 2003- October
2007
Inclusion criteria (cases): Patients hospitalized for
sepsis during the observation period were eligible.
Inclusion criteria (controls): Individuals with serious
infection who did not experience a hospitalization for
sepsis, matching for age (±5 years), sex, and time
epoch
Exclusion criteria: individuals hospitalized for
conditions unrelated to infections
N cases: 162
N controls: 162
NR not reported, COS community-onset sepsis, SIRS systemic inflammatory response syndrome, ED emergency department, ICU intensive care unit, ACCP/SCCM
American College of Chest Physicians/Society of Critical Care Medicine, GI gastrointestinal, CVD cardiovascular disease, OR odds ratio, 95% CI 95 percent
confidence interval, AIDS acquired immunodeficiency syndrome, NSAID non-steroidal anti-inflammatory drugs, IL-6 interleukin-6, TNF-α tumor necrosis factor alpha,
ICAM intercellular adhesion molecule, VCAM vascular cell adhesion molecule, DVT deep vein thrombosis, CKD chronic kidney disease, MI myocardial infarction, CAD
coronary artery disease
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Table 3 Incidence of community-onset sepsis: cohort studies
Study ID country Cohort and study
characteristics
Study design
and duration
of follow-up
Type of
sepsis
Incidence – overall (total cohort) Methodological
quality (high,
acceptable, low)
N of cases
per 100,000
population
per year
[95% CI]
CIP % per
hospitalisation
or ED visit per
year [95% CI]
IDR (N of
cases per
100,000 p-y)
[95% CI]
Esteban 2007 [46]
Spain
Geographic scope Prospective
cohort study
Non-severe 367 [352, 384] 13.28% [12.76, 13.81] NR Acceptable
quality
City/municipal Severe 104 [96, 113] 3.76% [3.47, 4.06] NR
FU: 4 months
Setting Septic shock 31 [27, 36] 1.11% [0.95, 1.28] NR
ICU, hospital ward
Cohort denominator
N (population)=573,149
N (hospitalisations)=15,852
Ginde 2013 [47]
The USA
Geographic scope Retrospective
cohort study
Severe NR 0.40% [0.39, 0.41] NR Low quality
Nationwide
Setting FU: 5 years
ED
Cohort denominator
N (population)=NR
N (all ED visits)=87,500,000
Harrison 2006 [11]
The UK
Geographic scope Retrospective
cohort study
Severe 66 [NR]μ 27.87% [27.52, 28.24] NR Acceptable
quality
Nationwide
Setting FU: 2 years
ICU, combination of ICU with
HDU
Cohort denominator
N (population)=NR
N (hospitalisations)=59,527
Henriksen 2015a
[42] Denmark
Geographic scope Prospective
cohort study
All 727 [693, 762] NR 731 [697, 767] Acceptable
quality
City/municipal Non-severe 264 [243, 285] NR 265 [245, 287]
Setting FU: 1 year Severe 455 [428, 482] NR 457 [430, 485]
ED, ICU Septic shock 9 [6, 13] NR 9 [6, 14]
Cohort denominator
N (population )=235,598
N (hospitalisations)=8,358
Husak 2010 [48]
Canada
Geographic scope Retrospective
cohort study
All 103 [NR]μ NR NR Low quality
Nationwide Non-severe 64 [NR]μ NR NR
Setting FU: 5 years Severe 40 [NR]μ NR NR
ED, ICU, hospital ward
Cohort denominator
N (population or
hospitalisations)=NR
Nygard 2014 [49]
Norway
Geographic scope Prospective
cohort study
Severe 50 [NR]μ 0.22% [NR]μ NR Low quality
City/municipal
Setting FU: 1 year
ED, ICU, HDU,
combination of ICU with HDU
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Race/ethnicity The effect of race was evaluated in
two cohort studies. In the first study, the risk of se-
vere sepsis in Black (OR adjusted =1.30, 95 % CI: 0.62,
2.60) or Hispanic (OR adjusted =0.63, 95 % CI: 0.23,
1.70) participants did not significantly differ from the
risk in White participants [47]. The second study
however showed White participants to be at a signifi-
cantly higher risk for non-severe sepsis compared to
Black participants (HRR adjusted =1.56, 95 % CI: 1.38,
1.75) [36].
Education One cohort study reported the risk of sepsis
by levels of education and found that lower levels of
education were associated with an increased risk of non-
severe sepsis (<high school vs. ≥college; HRR crude = 1.88,
95 % CI: 1.54, 2.29) [36].
Nursing home residence One retrospective cohort
study found a significant association between nursing
home residence and risk of severe sepsis (residence vs.
no residence; OR adjusted =2.60, 95 % CI: 1.20, 5.60) [47].
Table 3 Incidence of community-onset sepsis: cohort studies (Continued)
Cohort denominator
N (population or
hospitalisations)=NR
Page 2015 [50]
The USA
Geographic scope Retrospective
cohort study
Severe NR CA-SS NR Low quality
Nationwide 5.75% [5.72, 5.77]
Setting FU: 1 year HCA-SS
NR 2.37% [2.35, 2.38]
Cohort denominator
N (population)=NR
N (hospitalisations)=3,355,753
Wang 2012 [36]
REGARDS-sepsis
cohort study
2012-2015β The USA
Geographic scope Prospective
cohort study
Non-severe 514 [489, 539] NA 800 [760, 840] Acceptable
quality
Nationwide
Setting FU: 9-10 years
Hospital ward, ED
Cohort denominator
N (population)=30,239
N (hospitalisations)=NR
Seymour 2012 [51]
The USA
Geographic scope Retrospective
cohort study
Severe NR Entire 10-year
cohort
NR Low quality
Regional (within-State) 3.25% [3.20, 3.31]
Setting FU: 10 years One-year cohort
Pre-hospital emergency
medical services
4.93% [4.73, 5.13]
Cohort denominator
N (population)= NR
N (emergency
encounters)=407,176
Wang 2007 [52]
The USA
Geographic scope Retrospective
cohort study
Severe NR 0.69% [0.61, 0.77] NR Low quality
Nationwide
Setting FU: 4 years
ED
Cohort denominator
N (population)=NR
N (ED visits)=82,883,000
CIP cumulative incidence proportion, IDR incidence density rate, HR hazard rate, n/N number, p-y person-years, 95% CI 95 percent confidence interval; REGARDS
Reasons for Geographic And Racial Differences in Stroke, FU follow-up, ED emergency department, NA not applicable; NR not reported, ICU intensive care unit,
HDU high dependence unit, CA-SS community-acquired severe sepsis, HCA-SS healthcare-acquired severe sepsis
μ 95 % CIs cannot be calculated, due to the lack of denominator reported
β REGARDS-sepsis cohort study publications [32–38, 40, 41]
Tsertsvadze et al. Systematic Reviews  (2016) 5:81 Page 12 of 19
Table 4 Associations between socio-demographic factors and community-onset sepsis: cohort and case-control studies
Study ID
country
Geographic
scope and
setting
Study design
Sample size N
Type
of sepsis
Risk factor
(reference and
exposure groups)
Summary measure
of association
(exposure vs.
reference group)
95% CI
Covariates adjusted for Methodological
quality
Age (years)
Ginde 2013 [47]
The USA
Nationwide Retrospective cohort
study
Severe <65 Ref 1.00 sex and race/ethnicity Low quality
ED ≥65 OR=1.00 (0.52, 1.90)
N (cohort baseline –
all ED visits)=
87,500,000
Wang 2012 [36]
REGARDS-sepsis
cohort study β
2012-2015
The USA
Nationwide Prospective cohort
study
Non-severe 45-54 Ref 1.00 Not adjusted (crude) Acceptable
quality
Hospital ward,
ED
55-64 HRR=1.44 (1.04, 2.00)
N (cohort
baseline)=30,239 65-74 HRR=2.29 (1.66, 3.16)
75≤ HRR=3.87 (2.80, 5.35)
Henriksen
2015b [43]
Denmark
City/municipal Case-control study All 15-64 Ref 1.00 Sex, alcoholism- related
conditions, comorbidity,
and immunosuppression
Low quality
ED, ICU N (cases)=1,713 65-84 OR=3.09 (2.75, 3.48)
N (controls)=227,054 ≥85 OR=6.02 (5.09, 7.12)
Non-severe 15-64 Ref 1.00 See above
65-84 OR=2.15 (1.78, 2.60)
≥85 OR=3.66 (2.74, 4.88)
Severe 15-64 Ref 1.00 See above
65-84 OR=3.93 (3.39, 4.56)
≥85 OR=7.84 (6.38, 9.63)
Sex
Ginde 2013 [47]
The USA
Nationwide Retrospective cohort
study
Severe Female Ref 1.00 Age and race/ethnicity Low quality
ED Male OR=1.13 (0.62, 2.00)
N (cohort baseline–
all ED visits)=
87,500,000
Wang 2012 [36]
REGARDS-sepsis
cohort study β
2012-2015
The USA
Nationwide
Hospital ward,
ED
Prospective cohort
study analysis
Non-severe Female Ref 1.00 Not adjusted (crude) Acceptable
quality
N (cohort
baseline)=30,239
Male HRR=1.30 (1.15, 1.48)
Henriksen
2015b [43]
Denmark
City/municipal Case-control study All Female Ref 1.00 Age, alcoholism- related
conditions, comorbidity,
and immunosuppression
Low quality
ED, ICU N (cases)=1,713 Male OR=1.01 (0.91, 1.11)
N (controls)=227,054 Non-severe Female Ref 1.00 See above
Male OR=0.89 (0.76, 1.05)
Severe Female Ref 1.00 See above
Male OR=1.07 (0.95, 1.22)
Race/ethnicity
Ginde 2013 [47]
The USA
Nationwide Retrospective cohort
study
Severe Non-Hispanic White Ref 1.00 Age and sex Low quality
Non-Hispanic Black OR=1.30 (0.62, 2.60)
ED N (cohort baseline–
all ED visits)=
87,500,000
Hispanic OR=0.63 (0.23, 1.70)
Other OR=2.40 (0.87, 6.50)
Wang 2012 [36]
REGARDS-sepsis
cohort study β
2012-2015
The USA
Nationwide Prospective cohort
study analysis
Non-severe Black Ref 1.00 sex, age, geographic
region, education level,
income, tobacco, alcohol
use, baseline chronic
medical conditions,
biomarkers
Acceptable
quality
Hospital ward,
ED
N (cohort
baseline)=30,239
White HRR=1.56 (1.38, 1.75)
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Other factors Associations for anthropometric mea-
sures, life-style, clinical factors, medication use, and
serum biomarkers are provided in Additional file 4
(Table S3).
One prospective cohort study showed no evidence of
significant association between BMI groups in relation
to the risk of non-severe sepsis (≥40 kg/m2 vs. <24.9 kg/
m2; HRR adjusted =1.14, 95 % CI: 0.81, 1.62) [36]. The
same study however, showed an increased risk for non-
severe sepsis among current (HRR crude = 1.85, 95 % CI:
1.54, 2.22) and past tobacco smokers (HRR crude =1.64,
95 % CI: 1.42, 1.88) compared to never smokers. Moder-
ate alcohol use compared to no alcohol was associated
with a reduced risk of non-severe sepsis (HRR crude
=0.78, 95 % CI: 0.67, 0.89) [36]. Participants reporting
low levels of exercise (i.e., none) were at increased risk
of non-severe sepsis compared to those with high levels
of exercise (≥4 times per week; HRR adjusted =1.33, 95 %
CI: 1.13, 1.56).
One case-control and one cohort study demonstrated
that people with diabetes had an increased risk for all
sepsis (OR adjusted =1.82, 95 % CI: 1.57, 2.12) [43] and
non-severe sepsis (HRR adjusted =1.78, 95 % CI: 1.53,
2.07) [36]. Moreover, these two studies reported signifi-
cantly elevated risk of sepsis for patients with various
clinical conditions or disorders (e.g., immunosuppres-
sion, renal, psychotic, gastrointestinal, neurologic, car-
diovascular disease, cancer, lung disease, deep vein
thrombosis, stroke, atrial fibrillation) [36, 43].
Discussion
This systematic review summarised evidence on the bur-
den of COS in terms of incidence and risk factors from
14 studies.
Incidence of COS
Major findings
The annual population-based incidence rates (# of cases
per 100,000 population), as reported in the cohort studies
of low to acceptable quality, varied widely for non-severe
sepsis (range: 64–514), severe sepsis (range: 40–455), and
septic shock (range: 9–31). These results confirm sepsis as
a substantial health problem, but underline the uncer-
tainty in the precise burden of this condition. The variabil-
ity in estimates could be due to differences in the
underlying risk for sepsis, data sources, ICD-9/10 coding
practices, sepsis definition criteria, and statistical methods
of incidence estimation (e.g., choice of denominators,
dealing with incomplete outcome data).
It has been shown that different ICD-9/10 coding
practices (e.g., methods by Angus [3], Dombrovskiy [54],
and Martin [4]) used for severe sepsis cases alone may
lead to variable incidence estimates [28, 55–57]. Also,
there has been confusion in distinguishing bacteraemia,
septicaemia, and severe sepsis which are distinct clinical
conditions [13, 58–60]. The use of different data sources
may also have contributed to this variation. The use of
discharge diagnoses and different ICD codes have been
shown to produce variable estimates with mostly low
sensitivity and high specificity for correct identification
of sepsis [13]. Similarly, another study estimated that
discharge diagnoses had a high specificity (median:
98.5 %) and poor sensitivity (median: 42.4 %) for de-
tecting true cases of sepsis, thereby leading to mis-
classification and underdiagnosis of sepsis [57]. The study
by Wang et al. [18] corroborated these findings on the
sample of community-dwelling adults at risk for develop-
ing COS and found that the use of discharge databases
was highly specific and poorly sensitive for detecting COS
(94.6 % and 27.6 %, respectively). Although more
Table 4 Associations between socio-demographic factors and community-onset sepsis: cohort and case-control studies (Continued)
Education
Wang 2012 [36]
REGARDS-sepsis
cohort study β
2012-2015
The USA
Nationwide Prospective cohort
study analysis
Non-severe ≥College Ref 1.00 Not adjusted (crude) Acceptable
quality
Hospital ward,
ED
N (cohort
baseline)=30,239
Some college HRR=1.41 (1.19, 1.67)
High school HRR=1.52 (1.28, 1.80)
<High school HRR=1.88 (1.54, 2.29)
Nursing home residence
Ginde 2013 [47]
The USA
Nationwide Retrospective
cohort study
Severe No Ref 1.00 Age, sex and race/ethnicity Low quality
ED Yes OR=2.60 (1.20, 5.60)
N (cohort baseline)
= 87,500,000
NR not reported, ICU intensive care unit, HDU high dependence unit; ED emergency department, 95% CI 95 percent confidence interval, REGARDS Reasons for
Geographic And Racial Differences in Stroke, Ref reference group, OR odds ratio, HRR hazard rate ratio, NSAID non-steroidal anti-inflammatory drug, CKD chronic
kidney disease, IL-6 interleukin-6, TNF-α tumor necrosis factor alpha, ICAM intercellular adhesion molecule, VCAM vascular cell adhesion molecule, PSS perceived
stress scale, SD standard deviation, Q1-4 dietary intake quartile scores
β REGARDS-sepsis cohort study publications [32–38, 40, 41]
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resource-intensive, the utilisation of medical charts allows
to review physiologic and laboratory measurements which
then may be linked to an underlying infectious pathogen
with more certainty. Also, discharge databases unlike
medical records do not include the necessary information
needed to distinguish community-acquired and hospital-
acquired forms of sepsis [18].
The processes occurring over time such as population
aging, improvement in detection of sepsis, increased use
of immunosuppressive therapy, transplantation, and in-
vasive procedures may also explain the observed vari-
ation in sepsis incidence [61]. There is also evidence for
changes in the coding and definitions used for sepsis
over time. Rhee and colleagues assessed longitudinal
data for the annual sensitivity and incidence of discharge
ICD-9-CM codes for organ dysfunction (severe sepsis)
against clinical criteria [60], and found that from 2005 to
2013, the sensitivity of hospital discharge codes for de-
tecting hospitalisations with severe sepsis had gradually
increased (i.e., they have become more inclusive), while
clinical thresholds used for defining organ dysfunction
had decreased (i.e., they have become less restrictive).
The authors concluded that these changes may at least
partially explain the increased incidence of severe sepsis
over time [60, 62]. To further explore if the observed
trends in sepsis incidence have been influenced by the
choice of principal or secondary diagnosis codes, Walkey
and colleagues [63] using the US population-based sample
of hospitalisation claims for sepsis and specific sources of
infection (e.g., pneumonia, urinary tract infection, bacter-
aemia), calculated annual age-standardised hospitalisation
rates for sepsis or infections in 2003–2009. The study
showed increasing incidence trends for both sepsis (used
as principal diagnosis) and infection requiring mechanical
ventilation, with the former rising at a greater rate.
The between-study variation in the definitions and
methods for identifying and separating community-onset
from hospital-acquired sepsis may have also resulted in
different degrees of misclassification of sepsis cases,
thereby leading to additional variation in the incidence
of sepsis.
Strengths and limitations of the evidence
Currently, there is great uncertainty across the methods
of diagnosis and identification of sepsis. Different ICD-
9/10 coding practices yield different estimates of true in-
cidence, and there is no consensus as to which method
is more valid in correctly identifying sepsis cases.
The incidence of sepsis reported in 10 cohort studies
warrants a cautious interpretation. Specifically, 6 studies
were of low [47–52], while the remaining 4 studies were
of acceptable methodological quality [11, 36, 42, 46].
The findings from three studies of acceptable quality
may have limited applicability to the overall UK
population. For example, the annual incidence of non-
severe sepsis (514 per 100,000) reported in the cohort
study by Wang et al. [36] was dominated by high risk
populations (e.g., 60 % of the sample was 60 years or
older). The study by Henriksen and colleagues [42],
reporting the annual incidence of non-severe sepsis (264
cases per 100,000) was based on a single university-
based hospital, and the rates observed may not be ap-
plicable to a wider general population. Similarly, the
study by Esteban and colleagues, which also reported the
annual incidence of non-severe sepsis (264 cases per
100,000) covered only one small metropolitan area of
Spain and the study cohort had a short follow-up
(4 months) [46].
Consistency of findings
This review could not identify another systematic review
of COS in order to directly assess the consistency of
findings. Incidence rates of sepsis (regardless of the place
of acquisition) have been reported in several primary
studies [3, 4, 7–9, 28, 55, 64] and reviews [2, 10, 13, 58,
59, 65–67].
Most of the reported evidence pertains to the nation-
wide and regional incidence rates of severe sepsis rather
than non-severe sepsis. For example, a recent study
which used an administrative data from 20 % of US hos-
pitals compared the incidence rates of severe sepsis
using four methods of case ascertainment. Depending
on the method used, the incidence of severe sepsis var-
ied from 300 to 1,031 cases per 100,000 population per
year. In their cohort study, Karlsson and colleagues re-
ported an incidence of 38 cases of severe sepsis per
100,000 population per year [64]. An earlier study, based
on the 1995 US hospital discharge records reported an
estimate of 300 cases of severe sepsis per 100,000 US
population per year [3]. According to the Martin et al.
study, in 2000, the annual incidence of sepsis in the US
was estimated to be about 240 cases per 100,000 popula-
tion [4].
In one recent systematic review [66], the pooled inci-
dence rates restricted to the 2005–2015 years for sepsis
and severe sepsis were 437 (95 % CI: 334, 571; τ = 0.38)
and 270 (95 % CI: 176, 412; τ = 0.60) per 100,000 popu-
lation, respectively.
In general, the estimates of sepsis incidence and the
corresponding variability observed in this review were
consistent with those of other studies and reviews.
Risk factors of COS
Major findings
Overall, the limited amount of evidence from studies of
low to acceptable quality suggested a significantly in-
creased risk of sepsis (non-severe or severe) in associ-
ation with older age, Caucasian race, lower education,
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greater waist circumference, nursing home residence, to-
bacco use, physical inactivity, and various chronic clin-
ical conditions. Evidence for sex, body mass index,
alcohol use, statin/non-steroidal anti-inflammatory drug
use, and selected endothelial inflammation biomarkers
was inconsistent or inconclusive.
Strengths and limitations of the evidence
The evidence on risk factors for COS was sparse and
based mostly on studies of low methodological quality.
Therefore, caution should be exercised when interpret-
ing these results until more definitive evidence is avail-
able. Several factors such as selection bias, residual
confounding, exposure/outcome measurement misclassi-
fication, and multiple testing (i.e., type-I error) could
have accounted for some of the observed associations.
Of the 4 case-control studies, the control series in 3
studies were non-sepsis cases hospitalised for infections
or non-specified medical conditions [39, 44, 45]. The
controls used in the Henriksen et al. study were true
non-cases [43]. The use of hospital controls is prone to
selection bias if their exposure distribution is not repre-
sentative of that in the base population that gave rise to
cases [68]. For some studies, it was not clear if the
same exclusion criteria had been applied to cases and
controls. The use of different exclusion criteria may
lead to biased effect estimates for the reported risk
factors of sepsis [68].
Consistency of findings
The findings of this review on sex and race are not con-
sistent with those of recent studies not restricted to
COS. These studies report sex and racial disparities by
showing increased risk of sepsis among males (vs. fe-
males) and non-Caucasians (vs. Caucasians) [4, 69, 70].
In our review, one study corroborated these findings and
indicated that men were at higher risk for sepsis com-
pared to women [36], but two other studies showed no
such evidence [43, 47]. Regarding the effect of race, one
included in the review study indicated that Caucasians
compared to non-Caucasians were at higher risk of sep-
sis [33, 36] while another showed no significant differ-
ence between the two groups [47]. It is not clear
whether these discrepancies were due to the distinct as-
sociations applicable to COS, differences in the popula-
tion at risk, or sepsis coding practices across studies.
In agreement with previous research [10, 59], our re-
view also found that older age and the presence of clin-
ical chronic conditions are associated with an increased
risk for sepsis. This included clinical conditions that are
known to impair the human immune system, making
the patient more susceptible to various types of infec-
tion, among them sepsis.
Strengths and limitations of the review
This is the first systematic review of recent evidence on
the incidence and risk factors of COS. This review was
restricted to the evidence analysed in 2002 or later when
specific ICD-9 coding for non-severe sepsis (995.91), se-
vere sepsis (995.92), and septic shock (785.52) were in-
troduced [28]. The authors a priori operationalised all
methodological steps of this review.
There are several limitations to be acknowledged.
First of all, studies that used pre-2002 study data were
excluded given the changes in definition/coding prac-
tices, dynamic nature of sepsis incidence, and evolution
of associated pathogens. Although the restriction by
date limits the comprehensiveness of evidence and pre-
cision of the review findings, we believe that the pre-
2002 evidence would not reflect the current context of
sepsis accurately in light of the changes in sepsis epi-
demiology. Although non-English publications were not
included, to the best of our knowledge, we are not aware
of any empirical evidence showing the effects of lan-
guage bias on the incidence of sepsis. We also excluded
conference abstracts because they do not provide suffi-
cient information to distinguish COS from other types
of sepsis. The sparsity of evidence did not allow to ex-
plore the extent of publication bias. And finally, the
quality assessment tool for cohort studies may not have
been equally applicable to exposure and non-exposure
cohort studies. Due to poor reporting of publications
and subjective nature of study quality assessment tools
in general, some misclassification in quality ratings can-
not be ruled out.
Future research recommendations
Future research recommendations according to the PI-
COTS (Population, Intervention, Comparator, Outcome,
Timing, and Setting) framework along with the limita-
tions in evidence are provided as follows:
Population and Setting
Limitation(s) There is little evidence on the burden of
COS from nation-wide population-based cohort studies.
Most of the included cohort studies were hospital-
based, covered limited geographic areas, or recruited
high-risk subgroups and three of the four included case-
control studies utilised non-sepsis cases (i.e., hospital-
based controls) as controls which may have led to
underestimated associations between the risk factors
and sepsis.
Recommendation(s) More evidence is warranted from
well conducted population-based prospective cohort
studies with samples representative of any given gen-
eral population. These studies would ideally consist of
well-defined cohorts of participants free of sepsis at
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baseline. Future case-control studies would ideally
include random samples of population-based controls
from the same source population which gave rise to
sepsis cases.
Intervention and Comparator (exposure, risk factor groups)
Limitation(s) Due to poor reporting, for most of the
included studies it was not clear if the methods of expos-
ure measurement were valid. Misclassification of exposure
status may have biased the observed effect estimates for
risk factors of sepsis in any direction. Moreover, the
problem of multiple testing for various risk factors may
have led to type-I error (i.e., spurious statistically signifi-
cant results).
Recommendation(s) Future studies should ideally use
standard and validated methods of exposure measure-
ment. Better reporting of these methodologies used
would facilitate the methodological or risk of bias assess-
ment for researchers and practitioners involved in evi-
dence synthesis.
Outcome
Limitation(s) The estimates of COS incidence were
highly variable perhaps owing to well documented differ-
ences or changes in sepsis definition, diagnosis, and
ascertainment practices across studies.
Recommendation(s) The use of accurate and standard
methodology for sepsis surveillance and ascertain-
ment would ensure more valid estimation and com-
parability of sepsis incidence and risk factors across
studies.
Timing
Limitation(s) About 40 % of the included cohort studies
had a follow-up shorter than 2 years. Some of the esti-
mates of incidence may have been subject to seasonal
variation or any other extraneous factor.
Recommendation(s) Studies with longer follow-up are
needed to improve stability and precision around sepsis
incidence estimates
Policy implications
Improvements in the accuracy and consistency of sepsis
definition, diagnostic criteria, and standardisation of
methods for ascertainment of sepsis are prerequisites for
assessing the public health burden of sepsis reliably in
order to adequately inform public facing health cam-
paigns. A robust monitoring system to support evaluation
of any future interventions will require the development
of unbiased national surveillance. More studies inves-
tigating specific causative pathogens of sepsis (e.g.,
meningococcal sepsis) with the corresponding incidence,
and the related risk factors would provide additional evi-
dence needed to inform the policy for public facing health
campaigns targeted to specific causes of sepsis. The find-
ings of this review will help to inform recommendations
in relation to public facing campaigns targeting timely
presentation and diagnosis of sepsis in the community
and provide a policy for future public health planning.
Conclusion
This review found a highly variable annual population-
based incidence of non-severe (range: 64–514 per
100,000) and severe COS (range: 40–455 per 100,000),
likely due to different definitions and ascertainment
methods of sepsis across included studies. Limited evi-
dence identified several risk factors for sepsis (e.g., older
age, lower education, presence of clinical conditions, nurs-
ing home residence, and lower levels of physical activity).
Timeliness and accuracy of diagnosis of sepsis are both
crucial aspects for improving the patient’s outcome. It is
hoped that findings of this review will inform recom-
mendations on public facing campaigns to improve
timely presentation and diagnosis of sepsis in the
community and provide a basis for future research and
policy for public health planning.
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